University of California San Francisco
Give to UCSF<p>A proposed new treatment to help HIV/AIDS patients suffering from Kaposi’s sarcoma, the most common form of cancer in people with HIV, is now one step closer to becoming a reality thanks to a program that supports promising early-stage research.</p>
Cancer patients across the country have a new way to navigate through difficult treatment decisions and communicate better with their doctors. “Open to Options,’’ which recently launched nationally, was developed in conjunction with UCSF to guide patients in making critical health decisions.
People with lung cancer who are treated with the drug Tarceva face a daunting uncertainty: although their tumors may initially shrink, it's not a question of whether their cancer will return—it's a question of when. And for far too many, it happens far too soon.
<p>Vitamin D and calcium to prevent bone fractures in healthy, postmenopausal women does not work, at least at low supplemental doses, according to the United States Preventive Services Task Force.</p>
A new approach to drug design, pioneered by a group of researchers at UCSF and Mt. Sinai, New York, promises to help identify future drugs to fight cancer and other diseases that will be more effective and have fewer side effects.
The single thing that a woman can do to lower her risk of breast cancer is to avoid unnecessary medical imaging, says Rebecca Smith-Bindman, MD, a professor of radiology and biomedical imaging, epidemiology and biostatistics at UCSF, who contributed to a new Institute of Medicine report.
To celebrate nearly a quarter-century of advances in hematology and transplantation, UCSF is holding a reunion of patients from the UCSF Medical Center who have undergone bone marrow transplants.
<p>UCSF has seen a significant improvement in the career and work satisfaction of UCSF faculty over the last decade, according to the findings of a recent faculty climate survey. </p>
In a study of patients 65 and older with non-small-cell lung cancer (NSCLC), younger patients were more likely to receive treatment than older patients, regardless of overall health and prognosis.
A new brain cancer vaccine tailored to individual patients by using material from their own tumors has proven effective in a multicenter phase 2 clinical trial at extending their lives by several months or longer. The patients suffered from recurrent glioblastoma multiform — which kills thousands of Americans every year.
<p>The UCSF Family and Community Medicine Residency Program at San Francisco General Hospital and Trauma Center (SFGH) celebrates its 40th anniversary. It has trained more than 400 family doctors who have cared for tens of thousands of underserved patients and advocated for millions more.</p>